Home/Filings/4/0000950170-24-108233
4//SEC Filing

Sommadossi Jean-Pierre 4

Accession 0000950170-24-108233

CIK 0001593899other

Filed

Sep 18, 8:00 PM ET

Accepted

Sep 19, 8:02 PM ET

Size

9.9 KB

Accession

0000950170-24-108233

Insider Transaction Report

Form 4
Period: 2024-09-17
Sommadossi Jean-Pierre
DirectorPresident, CEO, and Chairman
Transactions
  • Sale

    Common Stock

    2024-09-17$4.05/sh33,941$137,3185,890,053 total(indirect: By LLC)
  • Sale

    Common Stock

    2024-09-18$4.03/sh22,187$89,4695,867,866 total(indirect: By LLC)
  • Sale

    Common Stock

    2024-09-19$4.00/sh1,841$7,3675,866,025 total(indirect: By LLC)
Holdings
  • Common Stock

    116,557
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.14. The Reporting Person undertakes to provide Atea Pharmaceuticals, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.0975. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.01. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

Atea Pharmaceuticals, Inc.

CIK 0001593899

Entity typeother

Related Parties

1
  • filerCIK 0001296995

Filing Metadata

Form type
4
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 8:02 PM ET
Size
9.9 KB